144 participants
PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-08-11
- Start Date:
- 2002-01-30
- Completion:
- 2008-03-27
Conditions
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
Interventions
- DRUG